Severe Malaria Clinical Trial
Official title:
Pharmacokinetics and Pharmacodynamics of Intravenous Artesunate in Treatment of Severe Malaria in Ugandan Patients
Intravenous artesunate is highly effective with rapid schizonticidal action and improved clinical outcome
The current first line treatment for severe malaria in Uganda is intravenous quinine with artemisinin derivatives as an alternative. Intravenous artesunate, a water soluble artemisinin derivative is more effective than quinine with faster schizonticidal action and improved clinical outcome. It is generally well tolerated and safe. This study aims is to assess the pharmacokinetics, pharmacodynamics and safety of IV artesunate in treatment of severe malaria in adults admitted to Mulago National Referral and Teaching hospital, Uganda. ;
Time Perspective: Prospective
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01955382 -
Evaluation of Oral Activated Charcoal on Antimalarial Drug's Ability to Kill Parasites in Malian Children With Malaria
|
Phase 2 | |
| Recruiting |
NCT04675931 -
To Evaluate Efficacy, Safety, Tolerability and PK of Intravenous Cipargamin in Participants With Severe Plasmodium Falciparum Malaria
|
Phase 2 | |
| Recruiting |
NCT05685875 -
Association of Diabetes and Metabolic Syndrome With Severe Malaria in Cameroon
|
||
| Completed |
NCT02451904 -
Severe and Cerebral Malaria Investigated Through Host Metabolomics
|
||
| Completed |
NCT04037332 -
Monitoring of Molecular Markers of Artemisinin Resistance Through Repeated Cross-sectional Assessments in DR Congo, Nigeria and Uganda
|
||
| Completed |
NCT00341003 -
Severe Malaria and Anti-malarial Drug Resistance in Cambodia
|
N/A | |
| Completed |
NCT01255215 -
Inhaled Nitric Oxide for the Adjunctive Therapy of Severe Malaria: a Randomized Controlled Trial
|
Phase 1/Phase 2 | |
| Completed |
NCT05140278 -
Study to Compare Feasibility of 1-step Injectable Artesunate vs. Conventional 2-step Injectable Artesunate
|
Phase 2 | |
| Recruiting |
NCT05711485 -
Platelet-Directed Whole Blood Transfusion Strategy for Malaria
|
N/A | |
| Completed |
NCT04473768 -
Clinical Decision Support in Non-typhoidal Salmonella Bloodstream Infections in Children
|
||
| Completed |
NCT04176029 -
Lung Ultrasound in Children With Severe Malaria
|
||
| Recruiting |
NCT06064591 -
Host Immune and Metabolic Determinants of Sexual Conversion in Plasmodium Parasites IMMETASEX
|
||
| Recruiting |
NCT04251351 -
Effect of Paracetamol on Kidney Function in Severe Malaria
|
Phase 3 | |
| Completed |
NCT00342043 -
Examination of Protective Factors Against Severe Malaria
|
N/A | |
| Completed |
NCT04516317 -
Very Severe Malaria Treated by Intravenous Artesunate
|
||
| Completed |
NCT01828333 -
Malaria Treatment With Injectable ArteSunate
|
N/A |